Cargando…

Induction of a Protective Heterosubtypic Immune Response Against the Influenza Virus by using Recombinant Adenoviral Vectors Expressing Hemagglutinin of the Influenza H5 Virus

Abstract Influenza viruses are characterized by a high degree of antigenic variability, which causes the annual emergence of flu epidemics and irregularly timed pandemics caused by viruses with new antigenic and biological traits. Novel approaches to vaccination can help circumvent this problem. One...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shmarov, M.M., Sedova, E.S., Verkhovskaya, L.V., Rudneva, I.A., Bogacheva, E.A., Barykova, Yu.A., Shcherbinin, D.N., Lysenko, A.A., Tutykhina, I.L., Logunov, D.Y., Smirnov, Yu.A., Naroditsky, B.S., Gintsburg, A.L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	A.I. Gordeyev 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347542/ https://www.ncbi.nlm.nih.gov/pubmed/22649637

Ejemplares similares

Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts
por: Tutykhina, Irina, et al.
Publicado: (2018)

The Analysis of B-Cell Epitopes of Influenza Virus Hemagglutinin
por: Shcherbinin, D.N., et al.
Publicado: (2016)

Effective Genetic Expression of Nanoantibodies by Recombinant Adenoviral Vector in vitro
por: Gribova, I.Yu., et al.
Publicado: (2011)

Recombinant Influenza Vaccines
por: Sedova, E.S., et al.
Publicado: (2012)

Toll-Like Receptors (TLRs): The Role in Tumor Progression
por: Shcheblyakov, D.V., et al.
Publicado: (2010)

Genetic Passive Immunization with Adenoviral Vector Expressing Chimeric Nanobody-Fc Molecules as Therapy for Genital Infection Caused by Mycoplasma hominis
por: Burmistrova, Daria A., et al.
Publicado: (2016)

Protective Immune Response against Bacillus anthracis Induced by Intranasal Introduction of a Recombinant Adenovirus Expressing the Protective Antigen Fused to the Fc-fragment of IgG2a
por: Shcherbinin, D. N., et al.
Publicado: (2014)

Severity of heterosubtypic influenza virus infection in ferrets is reduced by live attenuated influenza vaccine
por: Marriott, Anthony C., et al.
Publicado: (2021)

The differences in immunoadjuvant mechanisms of TLR3 and TLR4 agonists on the level of antigen-presenting cells during immunization with recombinant adenovirus vector
por: Lebedeva, Ekaterina, et al.
Publicado: (2018)

Non-neutralizing Antibodies Directed at Conservative Influenza Antigens
por: Sedova, E. S., et al.
Publicado: (2019)

Chlamydial Type III Secretion System Needle Protein Induces Protective Immunity against Chlamydia muridarum Intravaginal Infection
por: Koroleva, Ekaterina A., et al.
Publicado: (2017)

Heterosubtypic immune pressure accelerates emergence of influenza A virus escape phenotypes in mice
por: Chu, Julie TS, et al.
Publicado: (2022)

A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice
por: Bliss, Carly M., et al.
Publicado: (2022)

Heterosubtypic Immunity to Influenza A Virus Infections in Mallards May Explain Existence of Multiple Virus Subtypes
por: Latorre-Margalef, Neus, et al.
Publicado: (2013)

Regulation of the Target Protein (Transgene) Expression in the Adenovirus Vector Using Agonists of Toll-Like Receptors
por: Bagaev, A. V., et al.
Publicado: (2014)

Pre-existing heterosubtypic immunity provides a barrier to airborne transmission of influenza viruses
por: Le Sage, Valerie, et al.
Publicado: (2021)

Highly Pathogenic Avian Influenza Virus Infection of Mallards with Homo- and Heterosubtypic Immunity Induced by Low Pathogenic Avian Influenza Viruses
por: Fereidouni, Sasan R., et al.
Publicado: (2009)

Heterosubtypic immunity increases infectious dose required to infect Mallard ducks with Influenza A virus
por: Segovia, Karen M., et al.
Publicado: (2018)

Molecular Signatures of Hemagglutinin Stem-Directed Heterosubtypic Human Neutralizing Antibodies against Influenza A Viruses
por: Avnir, Yuval, et al.
Publicado: (2014)

Adaptive Heterosubtypic Immunity to Low Pathogenic Avian Influenza Viruses in Experimentally Infected Mallards
por: Segovia, Karen M., et al.
Publicado: (2017)

Triggering of Toll-like Receptor-2 in Mouse Myelomonocytic Leukaemia Cells WEHI-3B Leads to the Suppression of Apoptosis and Promotes Tumor Progression in Vivo
por: Shcheblyakov, D.V., et al.
Publicado: (2011)

Construction of a pIX-modified Adenovirus Vector Able to Effectively Bind to Nanoantibodies for Targeting
por: Garas, M. N., et al.
Publicado: (2014)

Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses
por: Kerstetter, Lucas J., et al.
Publicado: (2021)

Heterosubtypic cross‐protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration
por: Budimir, Natalija, et al.
Publicado: (2013)

Heterosubtype Neutralizing Responses to Influenza A (H5N1) Viruses Are Mediated by Antibodies to Virus Haemagglutinin
por: Garcia, Jean-Michel, et al.
Publicado: (2009)

Association of Mycoplasma hominis infection with prostate cancer
por: Barykova, Yulia A., et al.
Publicado: (2011)

Combined local and systemic immunization is essential for durable T-cell mediated heterosubtypic immunity against influenza A virus
por: Uddback, Ida E. M., et al.
Publicado: (2016)

Predicting the Evolutionary Variability of the Influenza A Virus
por: Timofeeva, T.A., et al.
Publicado: (2017)

Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines
por: Sridhar, Saranya
Publicado: (2016)

Cooperativity Between CD8+ T Cells, Non-Neutralizing Antibodies, and Alveolar Macrophages Is Important for Heterosubtypic Influenza Virus Immunity
por: Laidlaw, Brian J., et al.
Publicado: (2013)

Cross-reactivity between avian influenza A (H7N9) virus and divergent H7 subtypic- and heterosubtypic influenza A viruses
por: Guo, Li, et al.
Publicado: (2016)

Memory T Cells Generated by Prior Exposure to Influenza Cross React with the Novel H7N9 Influenza Virus and Confer Protective Heterosubtypic Immunity
por: McMaster, Sean R., et al.
Publicado: (2015)

Sequential Immunizations with heterosubtypic virus-like particles elicit cross protection against divergent influenza A viruses in mice
por: Luo, Yuan, et al.
Publicado: (2018)

Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice
por: Wohlbold, Teddy John, et al.
Publicado: (2015)

Wide Prevalence of Heterosubtypic Broadly Neutralizing Human Anti–Influenza A Antibodies
por: Sui, Jianhua, et al.
Publicado: (2011)

Immunity Against Heterosubtypic Influenza Virus Induced By Adenovirus And MVA Expressing Nucleoprotein And Matrix Protein-1
por: Lambe, Teresa, et al.
Publicado: (2013)

Heterosubtypic Antiviral Activity of Hemagglutinin-Specific Antibodies Induced by Intranasal Immunization with Inactivated Influenza Viruses in Mice
por: Muramatsu, Mieko, et al.
Publicado: (2013)

Heterosubtypic Protections against Human-Infecting Avian Influenza Viruses Correlate to Biased Cross-T-Cell Responses
por: Zhao, Min, et al.
Publicado: (2018)

A In Vitro and In Vivo Study of the Ability of NOD1 Ligands to Activate the Transcriptional Factor NF-kB
por: Tukhvatulin, A.I., et al.
Publicado: (2011)

Adjuvantation of an Influenza Hemagglutinin Antigen with TLR4 and NOD2 Agonists Encapsulated in Poly(D,L-Lactide-Co-Glycolide) Nanoparticles Enhances Immunogenicity and Protection against Lethal Influenza Virus Infection in Mice
por: Tukhvatulin, Amir, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1o8r42p2a3uoat7kjp33q4mbmk